NEW YORK (Reuters Health) - Colestimide, a resin that binds and eliminates bile acids, seems to be an effective treatment for obesity and type 2 diabetes -- at least in mice -- according to a report ...
Habegger is a professor in the UAB Department of Medicine Division of Endocrinology, Diabetes and Metabolism and also a scientist in the UAB Nutrition Obesity Research Center who studies how glucagon ...
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Precedent-setting submission includes data from post-marketing studies COBALT and Study 401 as ...
Take CHOLBAM at least 1 hour before or 4 to 6 hours (or at as great an interval as possible) after a bile acid binding resin. Aluminum-based Antacids: Aluminum-based antacids have been shown to adsorb ...
MORRISTOWN, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to ...
PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-term efficacy and safety ...
Sterols and bile acids, traditionally viewed as structural components and digestive surfactants, have emerged as critical ...
The target LDL-C level is progressively lower as the risk for CHD increases. The measured LDL-C level at which drug therapy should be initiated also is lower asthe risk for CHD increases. For example, ...
FOSTER CITY, Calif. & SAN DIEGO--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that they have entered into a definitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results